:: Class Utilisation Summary 2012
See LEGEND for key to shading and symbols.
:: Subject Area - PHAR Term - Semester 1
PHAR3102 | PHAR3251 | PHAR9101 | PHAR9102 | PHAR9107 | PHAR9111 |
PHAR9114 | PHAR9118 | PHAR9120 | PHAR9121 |
Data is correct as at Wed Sep 26 19:11:12 EST 2012
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
PHAR3102 | Molecular Pharmacology | ||||||
LAB | M10A | 7904 | Enr | Open | 38/40 | 95% | Mon 10-13 (w2-6,7-13, Wurth 204) |
LAB | M14A | 7905 | Enr | Open | 40/43 | 93% | Mon 14-17 (w2-6,7-13, Wurth 204) |
LEC | A | 7903 | Rel | Open | 78/80 | 98% | Thu 15-17 (w1-6,7-12, MathewsThD) |
TUT | F11A | 7907 | Rel | Open | 39/40 | 98% | Fri 11 (w1-5,7-13, Mat 130) |
TUT | H16A | 7906 | Rel | Open | 39/40 | 98% | Thu 17 (w1-5,7-13, MorvB G3) |
PHAR3251 | Clinical & Exp'l Pharmacology | ||||||
LAB | W15A | 4079 | Enr | Open | 38/40 | 95% | Wed 15-18/even (w2,4,6,8,10,12, Wurth 204) |
LAB | W15B | 4080 | Enr | Open | 29/40 | 73% | Wed 15-18/odd (Wurth 204) |
LEC | A | 4078 | Rel | Open | 67/80 | 84% | Mon 17 (w1-3,5-6,7-13, CLB 3); Thu 14 (w1-6,7-12, Biomed ThD) |
TUT | F10A | 4081 | Rel | Open | 52/80 | 65% | Fri 10 (w2-6,7-13, Law Th G02) |
TUT | F15A | 4082 | Rel | Open | 15/80 | 19% | Fri 15 (w2-6,7-13, Biomed ThE) |
PHAR9101 | Principles of Drug Action | ||||||
LEC | 01 | 1371 | Enr | Open | 22/30 | 73% | |
PHAR9102 | Pharm. Develp of New Medicines | ||||||
LEC | 01 | 1372 | Enr | Open | 21/30 | 70% | |
PHAR9107 | Therapeutics & Molec Basis of | ||||||
LEC | 01 | 1373 | Enr | Open | 9/30 | 30% | |
PHAR9111 | Pharmaceutical Formulation 2 | ||||||
LEC | 01 | 1378 | Enr | Open | 3/30 | 10% | |
PHAR9114 | Pharmacoeconomics | ||||||
LEC | 01 | 1374 | Enr | Open | 7/30 | 23% | |
PHAR9118 | Therap&Molec Basis of Disease2 | ||||||
LEC | 01 | 1377 | Enr | Open | 8/30 | 27% | |
PHAR9120 | Clinical Development of Med | ||||||
LEC | 01 | 1375 | Enr | Open | 21/30 | 70% | |
PHAR9121 | Postmarketing Development Med | ||||||
LEC | 01 | 1376 | Enr | Open | 22/30 | 73% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G Authorised by Deputy Vice Chancellor (Academic) & Registrar Privacy Statement Copyright & Disclaimer |